Physiological Saline Market Report 2025

This Physiological Saline market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The physiological saline market size has grown strongly in recent years. It will grow from $6.52 billion in 2024 to $7.11 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to the adoption of saline solutions in emergency medical services, rising demand for saline in surgical procedures, growing emphasis on infection control, regulatory standards mandating the use of sterile saline solutions, and increased awareness of the importance of hydration.

The physiological saline market size is expected to see strong growth in the next few years. It will grow to $9.96 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the integration of saline solutions in diagnostic procedures, expansion of the geriatric population, expansion of home healthcare services, consumer preference for natural and non-toxic products, and global efforts to improve access to essential healthcare supplies. Major trends in the forecast period include the development of specialized formulations of physiological saline, integration of physiological saline into telemedicine platforms, development of novel formulations, adoption of advanced packaging solutions, and technological innovations improving the safety and efficacy of saline solutions.

The growth of the physiological saline market is expected to be driven by the increasing number of surgical procedures. Surgical procedures involve medical interventions performed by trained healthcare professionals to diagnose, treat, or cure diseases, injuries, or abnormalities using invasive techniques such as incisions, excisions, sutures, and other manipulations. Several factors contribute to the rise in surgical procedures, including advancements in surgical methods, better access to healthcare services, and an aging population with greater medical needs, all of which are increasing the demand for surgical treatments. Physiological saline plays a vital role in surgical procedures by cleaning wounds, hydrating tissues, and acting as an irrigation medium. For example, according to a December 2023 report from the Australian Institute of Health and Welfare, an Australian government agency, 50% of patients were admitted for elective surgery within 49 days in 2022-23, compared to 40 days in 2021-22. This growing trend in surgical procedures is fueling the expansion of the physiological saline market.

Major companies in the physiological saline market are focusing on the development of innovative products, such as premixed hypertonic saline, which offers a ready-to-use solution. This helps healthcare professionals administer the correct amount of saline more efficiently and safely in emergency situations. Premixed hypertonic saline is a saline solution (sodium chloride) that has been prepared with a higher concentration of salt compared to regular saline. It is commonly used in medical treatments to address conditions like hyponatremia or to assist in lung therapy. For example, in April 2024, Delex Pharma International Inc., a US-based pharmaceutical manufacturer, introduced Axaline (Sodium Chloride). Axaline is the first premixed 3% hypertonic saline solution designed for severe hyponatremia, providing effective electrolyte replenishment for conditions such as hyponatremia, hypochloremia, and low salt syndrome.

In January 2023, Prestige Ameritech, a US-based manufacturer of disposable medical devices and automated machinery, acquired Anexa Biomedical for an undisclosed amount. This acquisition broadens Prestige’s product offerings to include sterile water and sterile saline, two products that have historically experienced shortages. Anexa Biomedical is a US-based manufacturer of saline solutions and sterile water.

Major companies operating in the physiological saline market are Cardinal Health Inc., Pfizer Inc., Fresenius Kabi AG, Merck KGaA, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd, Grifols S.A., VWR International LLC., B Braun Medical Inc, Spectrum Chemical, Enzo Life Sciences Inc, The Stevens Company Limited, Boreal Science, HiMedia Laboratories, AdipoGen Life Sciences Inc, Thistle Scientific., G-Biosciences, Enzymes Pharmaceuticals, Labogens, and Hamdan Healthcare.

North America was the largest region in the physiological saline market in 2024. The regions covered in the physiological saline market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the physiological saline market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Physiological saline, often referred to as saline solution, is a sterile mixture containing a specific concentration of sodium chloride (salt) dissolved in water, mirroring the salt concentration found in the human body. It is employed for numerous medical purposes, including wound cleaning, intravenous infusion, medication dilution, and irrigation of body cavities during surgeries. Physiological saline is essential for maintaining hydration, electrolyte balance, and cellular function, making it a vital component in healthcare settings for patient care, medical procedures, and emergency treatments.

The primary types of physiological saline are normal saline, hypertonic saline, and hypotonic saline. Normal saline, also known as isotonic saline, contains 0.9% sodium chloride in water, closely matching the salt concentration in human blood. The uses of physiological saline span acute health conditions, chronic diseases, skin abrasions, burns, and more, and it is utilized by various end users such as hospitals, clinics, recovery centers, and other healthcare facilities.

The physiological saline market research report is one of a series of new reports that provides physiological saline market statistics, including physiological saline industry global market size, regional shares, competitors with a physiological saline market share, detailed physiological saline market segments, market trends and opportunities, and any further data you may need to thrive in the physiological saline industry. This physiological saline market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The physiological saline market consists of sales of sterile saline solution, saline nasal spray, and saline eye drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.